Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02702414 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) |
| First Submitted : | March 3, 2016 |
| First Submitted that Met QC Criteria : | March 3, 2016 |
| First Posted : | March 8, 2016 (Estimate) |
| Results First Submitted : | January 7, 2022 |
| Results First Submitted that Met QC Criteria : | March 29, 2022 |
| Results First Posted : | April 4, 2022 |
| Last Update Submitted that Met QC Criteria : | October 11, 2023 |
| Last Update Posted : | October 18, 2023 |